Results 111 to 119 of about 319 (119)

In vitro activity of F901318 against filamentous fungi from cystic fibrosis patients

2018
Steinmann, Jörg, Dittmer, S., Heep, M., Rath, Peter-Michael   +3 more
openaire   +2 more sources

Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of Talaromyces marneffei

Antimicrobial Agents and Chemotherapy, 2021
Yun C Chang, Kyung Joo Kwon-Chung, Seyedmojtaba Seyedmousavi   +2 more
exaly  

In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis

Antimicrobial Agents and Chemotherapy, 2021
Seyedmojtaba Seyedmousavi, Yun C Chang, June Kwon-Chung   +2 more
exaly  

Potency of Olorofim (F901318) Compared to Contemporary Antifungal Agents against Clinical Aspergillus fumigatus Isolates and Review of Azole Resistance Phenotype and Genotype Epidemiology in China

Antimicrobial Agents and Chemotherapy, 2021
Huilin Su, Jan Zoll, Tobias G P Engel
exaly  

The Dynamic Influence of Olorofim (F901318) on the Cell Morphology and Organization of Living Cells of Aspergillus fumigatus

Journal of Fungi (Basel, Switzerland), 2020
Saskia du Pré, Michael J Bromley, Nick D Read   +2 more
exaly  

Activity of F901318 against azole-resistant and other difficult-to-treat Aspergillus species

2016
openaire   +1 more source

The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis

Antimicrobial Agents and Chemotherapy, 2018
Nathan P Wiederhold
exaly  

Pharmacodynamics of the Orotomides against Aspergillus fumigatus : New Opportunities for Treatment of Multidrug-Resistant Fungal Disease

MBio, 2017
William Hope, Ruwanthi Kolamunnage-Dona
exaly  

In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi

Medical Mycology
Catriona L Halliday, Tania C Sorrell, Monica A Slavin   +2 more
exaly